منابع مشابه
Shifting the paradigm in radiation safety.
The current radiation safety paradigm using the linear no-threshold (LNT) model is based on the premise that even the smallest amount of radiation may cause mutations increasing the risk of cancer. Autopsy studies have shown that the presence of cancer cells is not a decisive factor in the occurrence of clinical cancer. On the other hand, suppression of immune system more than doubles the cance...
متن کاملShifting the Parallel Programming Paradigm
Multicore computer architectures are now the standard for desktop computers, high-end servers and personal laptops. Due to the multicore shift in computer architecture, software engineers must write multithreaded programs to harness the resources of these parallel machines. Unfortunately, today’s parallel programming techniques are difficult to reason about, highly error-prone and challenging t...
متن کاملShifting the Paradigm in Hemolytic Uremic Syndrome.
In this issue of the journal, Ardissino et al1 report that early volume expansion in children with hemolytic uremic syndrome associated with Shiga toxinproducing Escherichia coli (STECHUS) significantly improves clinical outcomes. The observation possesses significant clinical implications for the management of an illness that causes much morbidity and not infrequently, mortality.2 The data are...
متن کاملThe Effectiveness of a Radiation Safety Training Program in Increasing the Radiation Safety Knowledge of Physicians: a Pilot Study
Background: Ionizing and non-ionizing radiation are widely used in the diagnosis and treatment of diseases. Considering the potential risks of radiation, radiation safety training courses are important for medical staff. Objective: The aim of this study was to investigate the effectiveness of one-day radiation safety training program in increasing the radiation safety knowledge of physicians....
متن کاملPalliative care--a shifting paradigm.
n engl j med 363;8 nejm.org august 19, 2010 781 Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates 4. with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 2005;23:6043-53. Schwartzentruber DJ, Lawson D, Richards J, et al. A phase III 5. multi-institutional randomized study of immunization with the gp100:209-217(210M)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dose-Response
سال: 2012
ISSN: 1559-3258,1559-3258
DOI: 10.2203/dose-response.11-056.doss